Abstract: A multifunctional mobility device which enables or assists a person to walk without assistance from another person. The device provides a practical solution to address the various levels of mobility assistance between the minimal support of a cane and the maximum support of a four-legged walker. The multiple functions of the device are enabled by changing width and height, and include a one-legged, two-handed walker; a two-legged, two-handed walker; a hemi-walker; a stair-climbing aide; a standard or bariatric cane; and a device providing assistance from the sitting to standing position. The device may employ a jointed handle of sufficient width to accommodate both hands, and two legs connected to the handle that move inward or outward in unison, using the jointed handle and a compound, articulating mechanism connecting the two legs.

Abstract: A multifunctional mobility device which enables or assists a person to walk without assistance from another person. The device provides a practical solution to address the various levels of mobility assistance between the minimal support of a cane and the maximum support of a four-legged walker. The multiple functions of the device are enabled by changing width and height, and include a one-legged, two-handed walker; a two-legged, two-handed walker; a hemi-walker; a stair-climbing aide; a standard or bariatric cane; and a device providing assistance from the sitting to standing position. The device may employ a jointed handle of sufficient width to accommodate both hands, and two legs connected to the handle that move inward or outward in unison, using the jointed handle and a compound, articulating mechanism connecting the two legs.

Abstract: The present invention relates to pharmaceutical compositions useful for the treatment of subjects suffering from an infection or disease caused by the hepatitis B virus (HBV). In particular, it has been discovered that the administration of low dosage amounts of 1-(2'-deoxy-2'-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (FIAU) to humans chronically infected with HBV is effective to reduce drastically circulating markers associated with HBV. The present invention is also directed to methods of the preparation of pharmaceutical antiviral compositions.

Abstract: A vaccination scheduler is used by health professionals to easily and unequivocally establish the appropriate timing and dosage for vaccinations routinely given to children. The invention clarifies the maze of instructions and caveats that otherwise must be born in mind by the health professional, resulting in much under-vaccination and disease. A sequence of vaccine-specific dials display the needed information in a sequence which indexes with the windows of a front panel to isolate the sequencing and dose information needed for the particular patient.

Abstract: A method of treating idiopathic thrombocytopaenia purpura with 2',3'-dideoxy-3'-azidonucleosides, in particular 3'-azido-3'-deoxythymidine, is disclosed.